United States Liposome Drug Delivery Market Report 2017

January 2017 | 124 pages | ID: U3F7DEF90ACEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liposome Drug Delivery

Revenue, means the sales value of Liposome Drug Delivery

This report studies sales (consumption) of Liposome Drug Delivery in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Johnson & Johnson
• Gilead Sciences
• Luye Pharma
• Sun Pharmaceutical
• Pacira
• Fudan-Zhangjiang
• Sigma-Tau Group
• Teva Pharmaceutical
• CSPC
• Novartis
• Crucell
• Celsion Corporation
• Kingond Pharm
• Shanghai New Asia
• Spectrum Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Liposomal doxorubicin
• Liposomal Amphoteracin B
• Liposomal Paclitaxel
• Other

Split by applications, this report focuses on sales, market share and growth rate of Liposome Drug Delivery in each application, can be divided into

• Fungal Infection Therapy
• Cancer Therapy ( Tumor therapy)
• Other

Contents

United States Liposome Drug Delivery Market Report 2017

1 LIPOSOME DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Liposome Drug Delivery
1.2 Classification of Liposome Drug Delivery
  1.2.1 Liposomal doxorubicin
  1.2.2 Liposomal Amphoteracin B
  1.2.3 Liposomal Paclitaxel
  1.2.4 Other
1.3 Application of Liposome Drug Delivery
  1.3.1 Fungal Infection Therapy
  1.3.2 Cancer Therapy ( Tumor therapy)
  1.3.3 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Liposome Drug Delivery (2011-2021)
  1.4.1 United States Liposome Drug Delivery Sales and Growth Rate (2011-2021)
  1.4.2 United States Liposome Drug Delivery Revenue and Growth Rate (2011-2021)

2 UNITED STATES LIPOSOME DRUG DELIVERY COMPETITION BY MANUFACTURERS

2.1 United States Liposome Drug Delivery Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Liposome Drug Delivery Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Liposome Drug Delivery Average Price by Manufactures (2015 and 2016)
2.4 Liposome Drug Delivery Market Competitive Situation and Trends
  2.4.1 Liposome Drug Delivery Market Concentration Rate
  2.4.2 Liposome Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Liposome Drug Delivery Sales and Market Share by States (2011-2016)
3.2 United States Liposome Drug Delivery Revenue and Market Share by States (2011-2016)
3.3 United States Liposome Drug Delivery Price by States (2011-2016)

4 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Liposome Drug Delivery Sales and Market Share by Type (2011-2016)
4.2 United States Liposome Drug Delivery Revenue and Market Share by Type (2011-2016)
4.3 United States Liposome Drug Delivery Price by Type (2011-2016)
4.4 United States Liposome Drug Delivery Sales Growth Rate by Type (2011-2016)

5 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Liposome Drug Delivery Sales and Market Share by Application (2011-2016)
5.2 United States Liposome Drug Delivery Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIPOSOME DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liposome Drug Delivery Product Type, Application and Specification
    6.1.2.1 Liposomal doxorubicin
    6.1.2.2 Liposomal Amphoteracin B
  6.1.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 Liposome Drug Delivery Product Type, Application and Specification
    6.2.2.1 Liposomal doxorubicin
    6.2.2.2 Liposomal Amphoteracin B
  6.2.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Luye Pharma
  6.3.2 Liposome Drug Delivery Product Type, Application and Specification
    6.3.2.1 Liposomal doxorubicin
    6.3.2.2 Liposomal Amphoteracin B
  6.3.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
  6.4.2 Liposome Drug Delivery Product Type, Application and Specification
    6.4.2.1 Liposomal doxorubicin
    6.4.2.2 Liposomal Amphoteracin B
  6.4.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Pacira
  6.5.2 Liposome Drug Delivery Product Type, Application and Specification
    6.5.2.1 Liposomal doxorubicin
    6.5.2.2 Liposomal Amphoteracin B
  6.5.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Fudan-Zhangjiang
  6.6.2 Liposome Drug Delivery Product Type, Application and Specification
    6.6.2.1 Liposomal doxorubicin
    6.6.2.2 Liposomal Amphoteracin B
  6.6.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Sigma-Tau Group
  6.7.2 Liposome Drug Delivery Product Type, Application and Specification
    6.7.2.1 Liposomal doxorubicin
    6.7.2.2 Liposomal Amphoteracin B
  6.7.3 Sigma-Tau Group Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical
  6.8.2 Liposome Drug Delivery Product Type, Application and Specification
    6.8.2.1 Liposomal doxorubicin
    6.8.2.2 Liposomal Amphoteracin B
  6.8.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 CSPC
  6.9.2 Liposome Drug Delivery Product Type, Application and Specification
    6.9.2.1 Liposomal doxorubicin
    6.9.2.2 Liposomal Amphoteracin B
  6.9.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.2 Liposome Drug Delivery Product Type, Application and Specification
    6.10.2.1 Liposomal doxorubicin
    6.10.2.2 Liposomal Amphoteracin B
  6.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Crucell
6.12 Celsion Corporation
6.13 Kingond Pharm
6.14 Shanghai New Asia
6.15 Spectrum Pharmaceuticals

7 LIPOSOME DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Liposome Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liposome Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liposome Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIPOSOME DRUG DELIVERY MARKET FORECAST (2016-2021)

11.1 United States Liposome Drug Delivery Sales, Revenue Forecast (2016-2021)
11.2 United States Liposome Drug Delivery Sales Forecast by Type (2016-2021)
11.3 United States Liposome Drug Delivery Sales Forecast by Application (2016-2021)
11.4 Liposome Drug Delivery Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liposome Drug Delivery
Table Classification of Liposome Drug Delivery
Figure United States Sales Market Share of Liposome Drug Delivery by Type in 2015
Figure Liposomal doxorubicin Picture
Figure Liposomal Amphoteracin B Picture
Figure Liposomal Paclitaxel Picture
Figure Other Picture
Table Application of Liposome Drug Delivery
Figure United States Sales Market Share of Liposome Drug Delivery by Application in 2015
Figure Fungal Infection Therapy Examples
Figure Cancer Therapy ( Tumor therapy) Examples
Figure Other Examples
Figure United States Liposome Drug Delivery Sales and Growth Rate (2011-2021)
Figure United States Liposome Drug Delivery Revenue and Growth Rate (2011-2021)
Table United States Liposome Drug Delivery Sales of Key Manufacturers (2015 and 2016)
Table United States Liposome Drug Delivery Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liposome Drug Delivery Sales Share by Manufacturers
Figure 2016 Liposome Drug Delivery Sales Share by Manufacturers
Table United States Liposome Drug Delivery Revenue by Manufacturers (2015 and 2016)
Table United States Liposome Drug Delivery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Liposome Drug Delivery Revenue Share by Manufacturers
Table 2016 United States Liposome Drug Delivery Revenue Share by Manufacturers
Table United States Market Liposome Drug Delivery Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Liposome Drug Delivery Average Price of Key Manufacturers in 2015
Figure Liposome Drug Delivery Market Share of Top 3 Manufacturers
Figure Liposome Drug Delivery Market Share of Top 5 Manufacturers
Table United States Liposome Drug Delivery Sales by States (2011-2016)
Table United States Liposome Drug Delivery Sales Share by States (2011-2016)
Figure United States Liposome Drug Delivery Sales Market Share by States in 2015
Table United States Liposome Drug Delivery Revenue and Market Share by States (2011-2016)
Table United States Liposome Drug Delivery Revenue Share by States (2011-2016)
Figure Revenue Market Share of Liposome Drug Delivery by States (2011-2016)
Table United States Liposome Drug Delivery Price by States (2011-2016)
Table United States Liposome Drug Delivery Sales by Type (2011-2016)
Table United States Liposome Drug Delivery Sales Share by Type (2011-2016)
Figure United States Liposome Drug Delivery Sales Market Share by Type in 2015
Table United States Liposome Drug Delivery Revenue and Market Share by Type (2011-2016)
Table United States Liposome Drug Delivery Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Liposome Drug Delivery by Type (2011-2016)
Table United States Liposome Drug Delivery Price by Type (2011-2016)
Figure United States Liposome Drug Delivery Sales Growth Rate by Type (2011-2016)
Table United States Liposome Drug Delivery Sales by Application (2011-2016)
Table United States Liposome Drug Delivery Sales Market Share by Application (2011-2016)
Figure United States Liposome Drug Delivery Sales Market Share by Application in 2015
Table United States Liposome Drug Delivery Sales Growth Rate by Application (2011-2016)
Figure United States Liposome Drug Delivery Sales Growth Rate by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Liposome Drug Delivery Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Liposome Drug Delivery Sales Market Share (2011-2016)
Table Luye Pharma Basic Information List
Table Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Luye Pharma Liposome Drug Delivery Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Liposome Drug Delivery Sales Market Share (2011-2016)
Table Pacira Basic Information List
Table Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pacira Liposome Drug Delivery Sales Market Share (2011-2016)
Table Fudan-Zhangjiang Basic Information List
Table Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fudan-Zhangjiang Liposome Drug Delivery Sales Market Share (2011-2016)
Table Sigma-Tau Group Basic Information List
Table Sigma-Tau Group Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sigma-Tau Group Liposome Drug Delivery Sales Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Liposome Drug Delivery Sales Market Share (2011-2016)
Table CSPC Basic Information List
Table CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSPC Liposome Drug Delivery Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Liposome Drug Delivery Sales Market Share (2011-2016)
Table Crucell Basic Information List
Table Celsion Corporation Basic Information List
Table Kingond Pharm Basic Information List
Table Shanghai New Asia Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liposome Drug Delivery
Figure Manufacturing Process Analysis of Liposome Drug Delivery
Figure Liposome Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2015
Table Major Buyers of Liposome Drug Delivery
Table Distributors/Traders List
Figure United States Liposome Drug Delivery Production and Growth Rate Forecast (2016-2021)
Figure United States Liposome Drug Delivery Revenue and Growth Rate Forecast (2016-2021)
Table United States Liposome Drug Delivery Production Forecast by Type (2016-2021)
Table United States Liposome Drug Delivery Consumption Forecast by Application (2016-2021)
Table United States Liposome Drug Delivery Sales Forecast by States (2016-2021)
Table United States Liposome Drug Delivery Sales Share Forecast by States (2016-2021)